Turning Point Therapeutics | SC 14D9/A: Tender offer solicitation/recommendation statements filed under Rule 14d-9 (Amendment)
Aug 16, 2022 07:10 ET
Turning Point Therapeutics | SC TO-T/A: Third party tender offer statement (Amendment)
Aug 16, 2022 07:08 ET
Turning Point Therapeutics | SC 14D9/A: Tender offer solicitation/recommendation statements filed under Rule 14d-9 (Amendment)
Aug 9, 2022 07:07 ET
Turning Point Therapeutics | SC TO-T/A: Third party tender offer statement (Amendment)
Aug 9, 2022 07:00 ET
Turning Point Therapeutics | SC 14D9/A: Tender offer solicitation/recommendation statements filed under Rule 14d-9 (Amendment)
Jul 19, 2022 07:28 ET
Turning Point Therapeutics | SC TO-T/A: Third party tender offer statement (Amendment)
Jul 19, 2022 07:13 ET
Turning Point Therapeutics | SC TO-T/A: Third party tender offer statement (Amendment)
Jul 1, 2022 16:11 ET
Turning Point Therapeutics | SC 14D9/A: Tender offer solicitation/recommendation statements filed under Rule 14d-9 (Amendment)
Jul 1, 2022 16:01 ET
Turning Point Therapeutics | SC 14D9: Tender offer solicitation/recommendation statements filed under Rule 14d-9
Jun 17, 2022 16:46 ET
Turning Point Therapeutics | SC TO-T: Third party tender offer statement
Jun 17, 2022 16:42 ET
Turning Point Therapeutics | SC14D9C: Written communication by the subject company relating to a third party tender offer
Jun 3, 2022 17:18 ET
Turning Point Therapeutics | SC TO-C: Written communication relating to an issuer or third party tender offer
Jun 3, 2022 17:15 ET
Turning Point Therapeutics | SC14D9C: Written communication by the subject company relating to a third party tender offer
Jun 3, 2022 09:05 ET
No Data
No Data